KFSHRC Heart Centre: A Leader in Advanced Cardiac Treatments Revolutionizing care from minimally invasive surgery to comprehensive outpatient services
King Faisal Specialist Hospital & Research Centre (KFSHRC) has solidified its position as a regional leader in advanced cardiac care. Its Heart Centre combines cutting-edge technology with exceptional outcomes, making it the top choice for patients from Saudi Arabia, the MENA region, and beyond.
Participating at Arab Health 2025, KFSHRC overviewed the Heart Centre's ground-breaking milestones that have redefined the landscape of cardiac care. These include performing the world's first fully robotic heart transplant in September 2024 through a novel procedure that minimizes complications and shortens recovery times, setting a global benchmark for minimally invasive surgery. Furthering this legacy, in January 2025, the Centre conducted the world's first robotic-assisted artificial heart pump implantation (HeartMate3), significantly improving recovery metrics and showcasing the transformative potential of robotic-assisted techniques.
Since the launch of its Robotic Cardiac Surgery Program in 2019, the Heart Centre has performed over 400 robotic surgeries with an impressive 98% survival rate. In 2024, outpatient visits rose by 32.2%, and new patient acceptance increased by 4.6%, reflecting the growing trust in the Centre's ability to manage complex cases while maintaining exceptional patient outcomes.
Following these achievements, KFSHRC's Heart Centre has become a premier destination for international patients seeking advanced cardiac treatments. In 2024 alone, KFSHRC treated patients from 17 countries, reflecting its growing reputation as a global leader in specialized healthcare.
King Faisal Specialist Hospital and Research Centre is a 2443-bed tertiary/quaternary care hospital with facilities in Riyadh, Jeddah, and Madinah in the Kingdom of Saudi Arabia. It has over 17,000 employees from over 63 nationalities. KFSHRC specialises in inpatient and outpatient medical care, with excellent centres in Oncology, Organ Transplantation, Cardiovascular Diseases, Neurosciences, and Genetic Diseases. It is recognised and ranked globally as one of the top hospitals, as on Newsweek's and Brand Finance's World's Best Hospitals—Top 250 lists. KFSHRC's International Services adhere to the highest global standards, reflected in the performance of 5K+ bone marrow and 4K+ solid organ transplants, 3K+ robotic-assisted procedures, 2K+ submitted cardiovascular inpatients annually, and much more.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mid East Info
2 days ago
- Mid East Info
KFSHRC Command Center at the Core of Digital Transformation and Care Excellence - Middle East Business News and Information
King Faisal Specialist Hospital & Research Centre (KFSHRC) has advanced healthcare efficiency through its Capacity Command Center, a strategic pillar in the hospital's digital transformation journey. The Center has significantly optimized hospital-wide performance while delivering more responsive, patient-centered care. Established to modernize operations and elevate care, the Center provides real-time visibility across the patient journey—from admission to discharge—powered by a locally developed color-coded alert system that flags bottlenecks and enables timely intervention. This has improved operational efficiency and patient experience by streamlining admissions, discharges, and transfers, resulting in faster recovery, better resource use, and smoother clinical handovers. Building on this foundation, the Center leverages AI and big data to forecast patient volumes, identify pressure points, and guide precise resource allocation. These capabilities are reinforced by ongoing technical reporting, data mining, and performance reviews that translate insights into continuous institutional improvement. These innovations have led to a 14% reduction in average length of stay (ALOS) and a 19% drop in emergency department congestion, boosting patient recovery, bed availability, and patient safety. In parallel, overall hospital activity grew, with new patient admissions increasing by 10.3% to 46,476 in 2024, reflecting enhanced throughput and capacity management. Central to KFSHRC's transformation agenda, the Command Center exemplifies how AI and real-time analytics enable predictive, evidence-based decisions, advancing its mission to deliver high-quality, specialized care through a scalable intelligent healthcare model. It is noteworthy that KFSHRC has been ranked first in the Middle East and Africa and 15th globally in the list of the world's top 250 Academic Medical Centers for the third consecutive year and recognised as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2025 Brand Finance rankings. Additionally, it was included in the World's Best Smart Hospitals list for 2025 by Newsweek magazine.
Mid East Info
5 days ago
- Mid East Info
KFSHRC Pioneering Clinical Trials and Gene Therapy Across the Region - Middle East Business News and Information
As part of Saudi Arabia's broader biotechnology transformation under Vision 2030, King Faisal Specialist Hospital & Research Centre (KFSHRC) solidified its role as the Kingdom's leading Clinical Trials hub in 2024 — conducting 52.4% of all active Clinical Trials nationwide, according to the Saudi National Institute of Health. This milestone reflects the sustained success of KFSHRC's Clinical Trials Transformation Initiative, launched in 2021 to build an integrated, patient-centered research ecosystem. By the end of 2024, the hospital had recorded 701 active research proposals, representing an 8% increase over the previous year. In Riyadh alone, research approvals rose by 20%, demonstrating growing alignment between scientific discovery and clinical care delivery. KFSHRC's research growth was matched by key innovation milestones. In 2024, it became the first in Saudi Arabia to locally produce CAR-T cells — a major step toward national self-sufficiency in advanced therapies. It also delivered a breakthrough in hemophilia care, using one-time gene therapy to restore clotting function in eight patients, eliminating preventive treatment and significantly improving quality of life. These advancements align closely with Saudi Arabia's Vision 2030 and National Biotechnology Strategy, which designate biotechnology as a national priority sector — aiming to localize therapeutic development, accelerate innovation, and establish global leadership by 2040. Complementing its scientific leadership, KFSHRC has also invested in public engagement, launching awareness campaigns in high-traffic public venues to promote Clinical Trials literacy and reduce misconceptions around participation. It is noteworthy that KFSHRC has been ranked first in the Middle East and Africa and 15th globally among the world's top 250 Academic Medical Centres for the third consecutive year, and recognised as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2025 Brand Finance rankings. Additionally, it was included in the World's Best Smart Hospitals list for 2025 by Newsweek magazine.
Mid East Info
27-05-2025
- Mid East Info
KFSHRC's 3D Medical Printing: Faster Surgeries, Fewer Complications
Riyadh: King Faisal Specialist Hospital & Research Centre (KFSHRC) has earned ISO 13485:2016 certification for its 3D Printing Services Department. This ISO certification represents the highest global standards for quality management systems in the design and manufacture of medical devices. It reflects the KFSHRC's strength in delivering innovative, custom-made solutions in complex clinical settings with rigorous quality control and assurance. KFSHRC's 3D Printing Services Department has become a cornerstone of the hospital's precision healthcare ecosystem. The department uses advanced additive manufacturing to produce patient-specific anatomical models, surgical guides, prosthetics and implants to improve surgical planning, reduce intraoperative risks, and augment clinical outcomes. In 2023, the department produced over 1,100 physical models and more than 5,000 digital simulations, which shortened average surgery time by 30% and reduced complications by 85%, significantly improving patient satisfaction. KFSHRC's achievements in this field have also garnered international recognition. The hospital was ranked among the top 20 Saudi government entities in the Emerging Technology Adoption Readiness Index for 2025. The Global Project Management Forum (GPMF) awarded its 3D Printing Project the 2024 Global Excellence Award in Technology Project Management. 'Our mission is to conduct cutting-edge, multidisciplinary research and integrate the innovative technologies into medical practice. Our expertise in 3D printing, artificial intelligence and robotics is combined to advance healthcare delivery. We are expanding our technology platforms and working towards our Kingdom's Vision 2030 to spin off a 3D printing medical technology company that would provide a broad healthtech and socioeconomic impact.' Notably, for the third consecutive year, KFSHRC has been ranked first in the Middle East and Africa and 15th globally in the list of the world's top 250 Academic Medical Centres. According to the 2025 Brand Finance rankings, it has been recognized as the most valuable healthcare brand in the Kingdom and the Middle East. Additionally, it was included in Newsweek magazine's World's Best Smart Hospitals list for 2025.
